Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease:Mechanisms and therapeutic perspectivesOA
Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease:Mechanisms and therapeutic perspectives
Ruizhe Ren;Siying Ren;Yihan Xu;Xiao Liang;Xiyang Wei
School of Life Sciences,Zhejiang Chinese Medical University,Hangzhou,Zhejiang,ChinaCollege of Life Science,Northwest Normal University,Lanzhou,Gansu,ChinaZhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases,Department of General Surgery,Sir Run-Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,ChinaZhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases,Department of General Surgery,Sir Run-Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,ChinaZhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases,Department of General Surgery,Sir Run-Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China
Metabolic dysfunction-associated steatotic liver disease(MASLD)Non-coding RNAs(ncRNAs)Regulatory networksBiomarkersTherapeutic strategies
Metabolic dysfunction-associated steatotic liver disease(MASLD)Non-coding RNAs(ncRNAs)Regulatory networksBiomarkersTherapeutic strategies
《肝脏研究（英文）》 2026 (2)
151-165,15
This work was supported by the National Natural Science Foundation of China(82400479)and the Research Project of Zhejiang Chinese Medical University(2025RCZXZK47).The au-thors would like to thank BioRender for drawing those figures.
评论